Acute myeloid leukemia (AML) post-high-dose cytarabine (HiDAC) outcomes: Academic versus collaborating community cancer centers.

Authors: Sruthi Dontu, Shawn Michael Doss, Mohammad Syam, Matthew Gold, Jacob Boccucci, Locke Johnson Bryan, Anand P. Jillella, Vamsi Kota

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e18538

Source: Full article

---

Abstract

e18538